Highlights and News

Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort - Arthritis Research & Therapy

Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort  Arthritis Research & Therapy

A longitudinal cohort study uncovers plasma protein biomarkers predating clinical onset and treatment response of rheumatoid arthritis - Nature

A longitudinal cohort study uncovers plasma protein biomarkers predating clinical onset and treatment response of rheumatoid arthritis  Nature

Deep molecular profiling of synovial biopsies in the STRAP trial identifies signatures predictive of treatment response to biologic therapies in rheumatoid arthritis - Nature

Deep molecular profiling of synovial biopsies in the STRAP trial identifies signatures predictive of treatment response to biologic therapies in rheumatoid arthritis  Nature

Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts - The Lancet

Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts  The Lancet

Deciphering the molecular landscape of rheumatoid arthritis offers new insights into the stratified treatment for the condition - Frontiers

Deciphering the molecular landscape of rheumatoid arthritis offers new insights into the stratified treatment for the condition  Frontiers

Computational approaches in rheumatic diseases - Deciphering complex spatio-temporal cell interactions - ScienceDirect.com

Computational approaches in rheumatic diseases - Deciphering complex spatio-temporal cell interactions  ScienceDirect.com

Associations between rheumatoid arthritis clinical factors with synovial cell types and states - medRxiv

Associations between rheumatoid arthritis clinical factors with synovial cell types and states  medRxiv

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials - The Lancet

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials  The Lancet

Queen Mary to lead multi-million pound rheumatoid arthritis research consortium - Queen Mary University of London

Queen Mary to lead multi-million pound rheumatoid arthritis research consortium  Queen Mary University of London

Clinical implications of synovial tissue phenotypes in rheumatoid arthritis - Frontiers

Clinical implications of synovial tissue phenotypes in rheumatoid arthritis  Frontiers

Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue - Nature

Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue  Nature

Identification of poor prognostic factors in randomized trials and observational cohort studies - researchgate.net

Identification of poor prognostic factors in randomized trials and observational cohort studies  researchgate.net

Rheumatoid arthritis - The Lancet

Rheumatoid arthritis  The Lancet

Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy - Frontiers

Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy  Frontiers

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial - Nature

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial  Nature

Addition of Fibroblast-Stromal Cell Markers to Immune Synovium Pathotypes Better Predicts Radiographic Progression at 1 Year in Active Rheumatoid Arthritis - Frontiers

Addition of Fibroblast-Stromal Cell Markers to Immune Synovium Pathotypes Better Predicts Radiographic Progression at 1 Year in Active Rheumatoid Arthritis  Frontiers

Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes - Frontiers

Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes  Frontiers

Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics - Nature

Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics  Nature

Clinical Applications of Synovial Biopsy - Frontiers

Clinical Applications of Synovial Biopsy  Frontiers